Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vascular Glue Seals Leaky Blood Vessels

By HospiMedica International staff writers
Posted on 30 Oct 2013
A surgical glue inspired by algae reduces blood loss by creating a mechanical seal during surgical reconstruction of large blood vessels, such as the carotid, femoral, brachial, and iliac arteries.

Seal-V is an adhesive based on alginate—a carbohydrate made by algae—which mimics the way algae adhere to rocks under water, binding strongly even in a wet environment, resolving the limitations of both protein-based and synthetic sealants. More...
The novel combination of an alginate pre-gel and a curing mesh allow surgeons absolute control of vascular sealing due to the fact that spreading is completely separated from the curing. Upon application of the hardening mesh, Seal-V cures within one minute, reducing unintentional dispersion and obviating difficult cleanup.

The sophisticated sealant is protein-free, strong, safe, biocompatible, and bioresorbable, and is intended to reinforce sutures but not replace them. The Seal-V applicator is ready for use, and does not require thawing, warming, or premixing prior to use. The viscous texture allows easy application and prevents the product from spreading on the surrounding tissue, while the conspicuous blue color facilitates visualization precise control of the curing process. Seal-V is a product of Sealantis (Haifa, Israel), and has received the European community CE marking of approval.

“The surgeon usually connects a synthetic vessel to a native vessel as part of a bypass procedure, and usually there is bleeding from the suture line. What we are trying to do is control the bleeding from the suture line,” said Tehilla Bar Yehuda, marketing manager for Sealantis, in an interview with Israel 21c. “And why is this a challenge? Vascular surgery patients are administered with blood thinners, so any bleeding during the surgery is very hard to stop.”

“There is always a place for another product, especially when we have so much trouble and problems with the current glues in place,” said Zeev Loberman, MD, head of the vascular surgery department in Bnai Zion Medical Center (Haifa, Israel). “It could be used for all kinds of operations. Any kind of surgery you could imagine: brain, lung, and general orthopedic surgery. In any place where you are getting in touch with bleeding that might interfere with the healing of a wound or where you are prolonging an operation and putting a burden on the patient.”

Related Links:

Sealantis
Bnai Zion Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.